APA (7th ed.) Citation

Colletta, A., Colletta, A., Cooper, K. M., Placentino, G., Devuni, D., Devuni, D., & Colletta, C. Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Colletta, Alessandro, Alessandro Colletta, Katherine M. Cooper, Giuseppe Placentino, Deepika Devuni, Deepika Devuni, and Cosimo Colletta. Sodium-glucose Cotransporter-2 Inhibitor Therapy Improves Renal and Hepatic Function in Patients with Cirrhosis Secondary to Metabolic Dysfunction Associated Steatotic Liver Disease and Type 2 Diabetes. Frontiers Media S.A.

MLA (9th ed.) Citation

Colletta, Alessandro, et al. Sodium-glucose Cotransporter-2 Inhibitor Therapy Improves Renal and Hepatic Function in Patients with Cirrhosis Secondary to Metabolic Dysfunction Associated Steatotic Liver Disease and Type 2 Diabetes. Frontiers Media S.A.